معرفی
Jonas Bergh is a Visiting Professor at Karolinska Institutet (KI) and holds the Mimi Althainz' Professorship in Oncology there. He serves as a senior consultant at Radiumhemmet, Karolinska University Hospital in Stockholm, and was recently appointed Director for the Strategic Research Program in Cancer at KI. Previously, he was Professor of Breast Oncology at Manchester University (2009-2010). His research focuses on tailored breast cancer treatment, including chemotherapy dosing and hormone therapy optimization through large-scale clinical trials.
- Current affiliations: Karolinska Institutet, Oxford University (Visiting Professor)
- Advisory roles: Chair of Scientific Advisory Group Oncology-Hematology at EMA, Co-chairman of Early Breast Cancer Trialists' Collaborative Group
- Scientific Contributions: Pioneered evidence-based duration of tamoxifen treatment and chemotherapy efficacy in breast cancer
- Awards: Fellow of Royal College of Physicians (London), WHO IARC Scientific Council member
۰مقاله منتشرشده
